You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》3D MEDICINES-B(01244.HK)今起招股 一手入場費13,252.23元
阿思達克 11-29 08:27
生物醫藥公司3D MEDICINES-B(01244.HK)公布招股詳情,擬全球發售1,635萬股,香港公開發售佔一成,國際發售佔九成。招股價介乎每股22.96至26.24元。每手500股計,一手入場費13,252.23元。該股今日(11月29日)起招股,下周三(12月7日)中午截止,預期將於12月15日掛牌。聯席保薦人為中金及中信建投國際。 公司上市引入4名基石投資者,包括徐州經開區(香港)、Harvest、TradArt Investment SP及Mobilewise,合共認購2.35億元公司股份。 如以招股價中位數24.6元計,公司上市料淨集資約2.45億元,當中約90%主要用於產品和候選藥物的研發、監管備案及商業化;約10%將用於一般企業及營運資金用途。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account